Efficacy of Montelukast and Ranitidine as an Add on Therapy for Chronic Urticaria

Abstract

Background: Chronic urticaria is a highly distressing disease affecting a person’s quality of life. In most cases, monotherapy fails. Hence, combinations of antihistamines with montelukast, H2 blockers, ciclosporin, dapsone, omalizumab are used with varying results. This study was done to assess the efficacy and safety of the combination therapy of Montelukast and Cetirizine with Ranitidine and Cetirizine in chronic urticaria patients . Methodology: In this randomized controlled study, hundred patients were recruited, randomized and medications were given to group A (Cetirizine + Montelukast) and group B (Cetirizine + Ranitidine). Complete history, clinical examination and laboratory investigations were done at the beginning of the study. Patients were educated to keep a daily record of Urticaria Activity Score (UAS7) over seven consecutive days in a descriptive chart. Review of patient’s UAS7 record and clinical examination were done at every weekend. Sum of score at the end of every week for 4 weeks were calculated and recorded. Results: The mean weekly UAS in group A were 18.67, 10.07, 4.65, and 1.74 and in group B were 27.77, 19.38, 13.68 and 8.04 respectively. Significant difference in symptom reduction between group A and group B was found to be favouring group A. The mean total UAS in group A was 35.13, group B is 68.87 (p < 0.001). Conclusion: Montelukast seems to be a promising medication as add-on therapy to Cetirizine both in the aspect of efficacy and safety in patients affected by chronic urticaria.

Authors and Affiliations

Sivagami Dinesh

Keywords

Related Articles

Evaluation of Health Related Quality of Life in Patient with Oral Cavity Squamous Cell Carcinoma Receiving Chemotherapy

Objective: To evaluate impact of chemotherapy on Health Related Quality of Life (HRQOL) in patients of oral cavity squamous cell carcinoma (OCSCC) by analysis of two different treatments named Concurrent Chemo - Radiatio...

Need for Pharmacogenomic Information Also for Generic Medications; Recommendation of the European Society of Pharmacogenomics and Theranostics (ESPT)

Need for Pharmacogenomic Information Also for Generic Medications; Recommendation of the European Society of Pharmacogenomics and Theranostics (ESPT)

The Discovery of Insulin and the Future for Insulin Replacement Therapy

Adequate consumption of antioxidants, such as vitamin E, is thought to be essential for optimal health. Nutritional surveys have shown below optimal levels of vitamin E intake for adults in the United States despite a va...

Deterioration of Brain Cell Function Induced by Dapoxetine Administration in Male Rats

Background and Aim of Work: Dapoxetine is a Selective Serotonin Reuptake Inhibitor (SSRI) decided for the remedy of premature ejaculation (PE) in adult men. The objective of this research was to determine the influence o...

Simulated Evaluation of Drug-Impaired Psychomotor Performance

The purpose of this placebo-controlled, randomized-crossover study was to evaluate a computer-based divided-attention task as a method for measure impaired human psychomotor performance. The ability of the divided-attent...

Download PDF file
  • EP ID EP529988
  • DOI 10.19070/2167-910X-1800048
  • Views 74
  • Downloads 0

How To Cite

Sivagami Dinesh (2018). Efficacy of Montelukast and Ranitidine as an Add on Therapy for Chronic Urticaria. International Journal of Clinical Pharmacology & Toxicology(IJCPT), 7(1), 290-295. https://europub.co.uk./articles/-A-529988